Cangene announced that the Biomedical Advanced Research and Development Authority will exercise options under a botulism antitoxin supply contract, which are expected to generate approximately US$61 million in additional revenue for Cangene over the next
News & Media
The LSAM job posting page connects qualified candidates eager to succeed in the life sciences to member organizations with open positions.
Province, University of Manitoba, GlaxoSmithKline Establish Endowed Research Chair to Study Infectious Disease
The creation of Manitoba’s first-ever research chair in the immunobiology of infectious disease at the University of Manitoba will further develop the province’s internationally-recognized expertise in infectious disease research.
Kane Biotech Inc. has won a significant new contract with a U.S. army medical research facility that will leverage other development opportunities for the firm.
New Program to Promote Business, Economic Growth: Province Will Invest $30 Million Over Five Years --Selinger
A new, $30-million Commercialization Support for Business Program has been established to promote and support entrepreneurism, commercialization and business development, Premier Greg Selinger announced
The Province of Manitoba and Manitoba Hydro are entering an agreement with Nissan Canada to work together on initiatives that will help advance the use of plug-in electric vehicles in the province, Innovation, Energy and Mines Minister Dave Chomiak announ
Valeant agreed to buy AB Sanitas for about 314 million euros ($442 million) to add dermatology drugs in eastern and central Europe
The Food Development Centre (FDC) is working with the Manitoba Agri-Health Research Network to make food a part of a treatment process to improve quality of life. Along with two other organizations working with the support of MAHRN (the Canadian Centre fo
The Richardson Centre for Functional Foods and Nutraceuticals is five years old and to mark the occasion it was joined by the Honourable Erin Selby, Minister of Advanced Education and Literacy, as it signed two international research agreements
The Sanford Project & DiaMedica announced the successful completion of a study involving DM-199 in preventing the onset of Type 1 diabetes in the non-obese diabetic mouse model
GVI Clinical Development Solutions Inc. and Guangzhou, China based Guangzhou IRD Medicine Company, announce the signing of a Memorandum of Understanding to create a joint venture company called IRD-CDS, based in China
Premier Greg Selinger announced a new Science Education Action Plan that includes $25 million over five years for science classroom renewal, teacher training and new strategic partnerships to promote Manitoba's science programming
Regulations for foods and natural health products, and what you can say about them, vary from country to country.
DiaMedica announced the company's entry into an evaluation agreement with the National Institute of Allergy and Infectious Diseases, a component of the U.S. National Institutes of Health
Valeant filed with the Securities and Exchange Commission a presentation in connection with its written consent solicitation to stockholders of Cephalon, Inc. for removal of Cephalon's current Board of Directors and election of its seven nominees in their
Premier Greg Selinger today announced the province is committing to invest $70 million in a new-state-of-the-art facility for CancerCare Manitoba to improve diagnostics, treatment and research that will help Manitoba families affected by this disease.
Valeant Pharmaceuticals International, Inc. announced that it had made a proposal to the Board of Directors of Cephalon, Inc. to acquire Cephalon for $73.00 per share in cash
Kane Biotech announced a non-brokered private placement offering for gross proceeds of up to $1,500,000 from the sale of up to 12,500,000 units at a price of $0.12 per unit
IMRISNV will provide important new capabilities for clinicians at University of Utah Hospital's leading edge stroke center
Valeant Pharmaceuticals International is Among the Companies in the Healthcare Sector With the Best Relative Performance
Valeant Pharmaceuticals International ranks first among companies in the Healthcare sector as measured by relative performance
A two-year-long clinical study on the health benefits of flax seeds is complete and, depending on the results, it could yield a rich supply of potential products for commercialization